Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
Schiller
Ampronix

New Ultrasound Applications Detects Early Response to Pancreatic Cancer Therapy

By Medimaging International staff writers
Posted on 06 Mar 2013
Image: 3-D Ultrasound Molecular Imaging (USMI) images of nonresponder and responder pancreatic xenografts before (day 0) and after (day 2) treatment. The grayscale image shows a volume of the tumor and surrounding tissue. The green region is the molecular signal (Photo courtesy of the University of North Carolina).
Image: 3-D Ultrasound Molecular Imaging (USMI) images of nonresponder and responder pancreatic xenografts before (day 0) and after (day 2) treatment. The grayscale image shows a volume of the tumor and surrounding tissue. The green region is the molecular signal (Photo courtesy of the University of North Carolina).
In a recent study, investigators utilized dynamic contrast enhanced-perfusion imaging (DCE-PI) and ultrasonic molecular imaging (USMI) to gauge response to therapy for pancreatic cancer.

The research was published in the January 2013 issue journal Technology in Cancer Research and Treatment. Paul Dayton, PhD, University of North Carolina (UNC) Lineberger Comprehensive Cancer Center (Chapel Hill, USA), and senior author of the study, said, “What we found is that using two noninvasive technologies, we can detect response to therapy earlier than by relying on tumor volume changes. Having new noninvasive, inexpensive technologies available to measure response to therapy earlier during the course of treatment would be a significant advance in the ability to tailor a person’s treatment to improve outcomes.”

Dr. Dayton, a UNC associate professor of biomedical engineering, worked with Jen Jen Yeh, M.D, an associate professor of surgery and pharmacology, to assess the imaging technologies on human pancreatic cancer in a preclinical model. Both investigators are members of the Lineberger Comprehensive Cancer Center.

USMI has the ability to depict noninvasively the biologic processes at the cellular and molecular levels. It accomplishes this with the use of targeted contrast agents, which are markers that bind to specific proteins expressed on cancer cells within the body. These contrast agents enable a conventional ultrasound system to identify signals from cancer cells that would otherwise be undetectable.

Ultrasound DCE-PI is a technique used noninvasively to track the blood flow in the microcirculation. Because growing tumors require abnormally increased blood flow, alterations in blood vessel structure or density can provide data regarding tumor malignancy. The researchers employed a drug that suppresses a protein specific to tumors. They then used the imaging applications to gauge the response of two different tumors, one known to respond to the drug therapy, and a second known not to respond. The findings indicated that USMI was able to detect molecular signs of tumor response to therapy after only two days.

A change in blood flow in the tumor was seen to detect response after day 14 using DCE-PI. Over the same period, standard volume measurements were not able to detect therapeutic response, and prior studies suggested that volume measurements do not become indicative of response until approximately 28 days. Therefore, these modalities revealed a substantial improvement in the early identification of tumor response to therapy, using contrast enhanced ultrasound imaging.

The contrast agents for USMI currently in clinical trials in Europe for cancer imaging, however, they are not yet available in the United States.

Related Links:
University of North Carolina Lineberger Comprehensive Cancer Center



Channels

Radiography

view channel

Brain Imaging Study Identifies Biological Differences Between PTSD and Traumatic Brain Injuries

The results of a study intended to help identify the biological differences, and treatment options for Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI) have been published in the April 2015 special US Veterans Issue of the journal Brain Imaging and Behavior. The research team which included brain-imaging... Read more

MRI

view channel
Image: The ViewRay MRIdian System (Photo courtesy of ViewRay).

Unique MRI-Guided Radiation Therapy System Showcased at ESTRO 2015

ViewRay (Cleveland OH, USA) has demonstrated their advanced radiation therapy technology for the treatment of cancer at the April, 2015, European Society for Therapeutic Radiology and Oncology (ESTRO)... Read more

Nuclear medicine

view channel
Image: PET scan images (Courtesy of King’s College London).

Preventing Unnecessary Radiotherapy for Patients with Early-Stage Hodgkin’s Lymphoma

A new study suggested that patients with early-stage (stage 1a or 2a) Hodgkin’s lymphoma disease, who underwent three cycles of chemotherapy with the drugs doxorubicin, bleomycin, vinblastine, and dacarbazine... Read more

General/Advanced Imaging

view channel

Global Healthcare Study of Coronary Artery Disease Reaches Significant Milestone

A major milestone has been reached in the Lipid-Rich Plaque (LRP) study, a prospective, multicenter clinical trial with the potential to reveal breakthrough correlations between Lipid-Rich Plaques and occurrence of heart attacks. The LPR study has now enrolled 1,000 patients, and aims to identify a correlation between... Read more

Imaging IT

view channel

Childhood Radiation Exposure Can Be Reduced Significantly Using EMR Decision Support

The results of a study to find ways to reduce the pediatric radiation burden have been published in the May 8, 2015, issue of the Journal of the American Board of Family Medicine. The study included 115 physicians from 17 US military family medicine training programs, and aimed to find whether an existing clinical decision... Read more

Industry News

view channel

Medical Imaging Company Recognized for Focus on Customer Partnerships

A company is recognized for excellence in its growth strategy and implementation, a high degree of product and technology innovation, and leadership. Frost & Sullivan (Mountain View, CA, USA) has awarded the 2015 North American Frost & Sullivan Medical Imaging Company of the Year award to Toshiba America Medical... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.